NASDAQ$IGMS

IGM Biosciences Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

IGMS Q4 2023 — extraction skipped

IGM Biosciences Inc filed Form 8-K (accession 0000950170-24-027952) for Q4 2023, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.

  • Form 8-K filed; press release body not parseable here.
  • Reason: no headline numerics found by parser nor by Financial Datasets fallback.
  • Numerics rely on the Financial Datasets fallback.

Headline financials

Total Revenue

$651K

Previous: $372K+75.0%
EPS (adj)

-$1.01

Previous: -$1.19+15.1%
Capital Expenditures

-$1.45M

Previous: $2.7M-153.7%
Net Income

-$60.7M

Previous: -$48.2M-25.9%
Operating Income

-$65.1M

Previous: -$56.3M-15.7%
Gross Profit

-$1.53M

No prior period
R&D Expense

$52M

No prior period
Stock-Based Comp

$9.24M

Previous: $11.1M-16.9%

Revenue & EPS history

IGM Biosciences · Revenue · Quarterly

$651K

Q4 2023+75%vs Q4 2022
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Revenue by segment

IGM Biosciences · $2.68M total across 1 segment · Q4 2024

  • Collaboration Revenue
    $2.68M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+4.2%

Avg return

Earnings day

-6.5%

Avg return

5 days after

-4.3%

Avg return

30 days after

58%

14 / 24 earnings

Positive

+72.4%

Q4 2021

Best reaction

-20.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025
Q2 2025+0.0%+0.8%
Q1 2025+4.2%+1.7%+3.4%
Q4 2024-2.4%-8.0%+5.6%
Q3 2024-10.4%-21.9%-27.9%
Q2 2024+4.4%+7.8%+38.5%
Q1 2024+1.9%-7.2%-17.3%
Q4 2023+2.4%-18.5%-28.1%
Q3 2023+7.3%
Q2 2023-7.1%
Q1 2023+6.7%
Q4 2022-20.4%
Q3 2022-9.9%
Q2 2022+22.2%
Q1 2022-7.5%
Q4 2021+72.4%
Q3 2021+15.9%
Q2 2021+8.9%
Q1 2021+10.9%
Q4 2020+4.1%
Q3 2020-4.2%
Q2 2020-4.2%
Q1 2020+5.6%
Q4 2019-1.8%
Q3 2019+1.2%
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro